StockMacro
Menu

Globus Medical

$66.89 -21% in 6 monthsMarket cap $8.9B

GMED on XNYS, Health Care, GLOBUS MEDICAL INC, job postings

Measures activity, not value. Not investment advice.

Shares down 19% in a year while 12-month profit rose 32% to $557.6M and short interest is 7.0%.

  • BadShort interest up 15% since the report two weeks earlier
  • BadLatest quarter revenue down 0.7% on the year before

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Through innovative technology and M&A activity, Globus Medical transformed into the number two medical device manufacturer in the competitive spine market. The firm was founded in 2003 with a heavy focus on internal research and development but vaulted its market share in 2023 through a merger with former competitor NuVasive. In 2025, the company acquired Nevro, a smaller player that specialized in spinal cord stimulation therapy. Globus Medical reports two business segments, musculoskeletal solutions and enabling technologies, which consist of implants used in surgery and associated technologies that assist the physician.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
6,000
Website
globusmedical.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 6 Jan 2027 (an estimate: a year ago it reported on 7 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $763.7M, net income $141.2M.
Quarter to 31 Dec 2021: revenue $250.0M, net income $15.1MQuarter to 31 Dec 2021: revenue $250.0M, net income $15.1MQuarter to 31 Mar 2022: revenue $230.5M, net income $38.1MQuarter to 31 Mar 2022: revenue $230.5M, net income $38.1MQuarter to 30 Jun 2022: revenue $263.6M, net income $54.6MQuarter to 30 Jun 2022: revenue $263.6M, net income $54.6MQuarter to 30 Sep 2022: revenue $254.1M, net income $47.4MQuarter to 30 Sep 2022: revenue $254.1M, net income $47.4MQuarter to 31 Dec 2022: revenue $274.5M, net income $50.1MQuarter to 31 Dec 2022: revenue $274.5M, net income $50.1MQuarter to 31 Mar 2023: revenue $276.7M, net income $49.1MQuarter to 31 Mar 2023: revenue $276.7M, net income $49.1MQuarter to 30 Jun 2023: revenue $291.6M, net income $57.7MQuarter to 30 Jun 2023: revenue $291.6M, net income $57.7MQuarter to 30 Sep 2023: revenue $383.6M, net income $998KQuarter to 30 Sep 2023: revenue $383.6M, net income $998KQuarter to 31 Dec 2023: revenue $616.5M, net income $15.0MQuarter to 31 Dec 2023: revenue $616.5M, net income $15.0MQuarter to 31 Mar 2024: revenue $606.7M, net income -$7.1MQuarter to 31 Mar 2024: revenue $606.7M, net income -$7.1MQuarter to 30 Jun 2024: revenue $629.7M, net income $31.8MQuarter to 30 Jun 2024: revenue $629.7M, net income $31.8MQuarter to 30 Sep 2024: revenue $625.7M, net income $51.8MQuarter to 30 Sep 2024: revenue $625.7M, net income $51.8MQuarter to 31 Dec 2024: revenue $657.3M, net income $26.5MQuarter to 31 Dec 2024: revenue $657.3M, net income $26.5MQuarter to 31 Mar 2025: revenue $598.1M, net income $75.5MQuarter to 31 Mar 2025: revenue $598.1M, net income $75.5MQuarter to 30 Jun 2025: revenue $745.3M, net income $202.8MQuarter to 30 Jun 2025: revenue $745.3M, net income $202.8MQuarter to 30 Sep 2025: revenue $769.0M, net income $119.0MQuarter to 30 Sep 2025: revenue $769.0M, net income $119.0MQuarter to 31 Dec 2025: revenue $826.4M, net income $140.6MQuarter to 31 Dec 2025: revenue $826.4M, net income $140.6MQuarter to 31 Mar 2026: revenue $759.9M, net income $124.3MQuarter to 31 Mar 2026: revenue $759.9M, net income $124.3MQuarter to 30 Jun 2026: revenue $789.6M, net income $151.6MQuarter to 30 Jun 2026: revenue $789.6M, net income $151.6MQuarter to 30 Sep 2026: revenue $763.7M, net income $141.2MQuarter to 30 Sep 2026: revenue $763.7M, net income $141.2M
31 Dec 2021RevenueNet incomeNet losstallest bar $826.4M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$763.7M$141.2M
30 Jun 2026$789.6M$151.6M
31 Mar 2026$759.9M$124.3M
31 Dec 2025$826.4M$140.6M
30 Sep 2025$769.0M$119.0M
30 Jun 2025$745.3M$202.8M
31 Mar 2025$598.1M$75.5M
31 Dec 2024$657.3M$26.5M
30 Sep 2024$625.7M$51.8M
30 Jun 2024$629.7M$31.8M
31 Mar 2024$606.7M-$7.1M
31 Dec 2023$616.5M$15.0M
30 Sep 2023$383.6M$998K
30 Jun 2023$291.6M$57.7M
31 Mar 2023$276.7M$49.1M
31 Dec 2022$274.5M$50.1M
30 Sep 2022$254.1M$47.4M
30 Jun 2022$263.6M$54.6M
31 Mar 2022$230.5M$38.1M
31 Dec 2021$250.0M$15.1M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $3.1B $2.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +13% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $557.6M $423.8M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $4.06 $3.10
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 69.1% 65.3% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 21.6% 13.4% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 17.8% 15.3% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 12.1% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $766.5M $579.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $517.4M $390.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $35.72
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 16.1 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.9 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.9 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Globus MedicalGMED (this company) $8.9B16.12.9+13%17.8%
InsuletPODD $9.2B21.52.9+26%13.4%
TeleflexTFX $6.4B21.02.8+21%13.5%
PenumbraPEN $12.6B80.18.1+17%10.1%
Baxter InternationalBAX $13.1Bloss1.1+6.0%-6.0%
GlaukosGKOS $14.0Bloss20.3+47%-24.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$5.8M

bought $0, sold $5.8M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+4.3%

611 13F filers vs 586

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

89%

119.3M shares held by 13F filers (30 Sep 2026) of 134.3M outstanding (4 Aug 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.0%

9.5M shares sold short (30 Oct 2026) of 134.3M outstanding (4 Aug 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

8.1

9.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+15%

8.2M shares sold short in the report before, 9.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

41%

41% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 61%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

+32%

33 vs 25 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-0.7%

$763.7M vs $769.0M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+13%

$40.4M vs $35.8M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$1.8M

the 12 months before: $2.1M

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

28

28 articles in the last 7 days; its usual week has 5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.6×

28 articles in the last 7 days; its usual week has 5.

Price $66.89 on 20 Nov 2026, -19% over 12 months (12-month range $66.89 to $96.82)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $15.3M in the last 12 months (the 12 months before: -$8.4M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 33 published in the last 12 months, +32% on the 12 months before.
Revenue per quarter. Revenue $763.7M in the latest quarter, -0.7% on a year earlier.
Capital spending per quarter. Capital spending $40.4M in the latest quarter, +13% on a year earlier.
Institutional holders (13F filers). 611 13F filers reported holding it in the latest 13F quarter, +31% on a year earlier.
Federal obligations. Federal obligations: $2.0M published in the last 12 months, +3.2% on the 12 months before.
Lobbying spend. Lobbying spend: $0 published in the last 12 months, -100% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
21 Oct 2026Lobbying filinglobbying engagement terminated (BALLARD SPAHR LLP)
4 Jun 20268-K and other filingsDirector or officer change
23 Mar 20268-K and other filingsDirector or officer change
23 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Feb 2026Sharp changeQuarterly revenue change: quarterly revenue change, 826.4M vs usual 627.7M (2025-12-31); 1.3x the same period a year earlier
21 Jul 20258-K and other filingsDirector or officer change
5 Jun 20258-K and other filingsDirector or officer change
5 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Apr 20258-K and other filingsCompleted an acquisition or asset sale
12 Nov 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 42.0M vs usual 19.9M (2024-09-30); 1.9x the same period a year earlier
13 Aug 2024Sharp changeQuarterly revenue change: quarterly revenue change, 629.7M vs usual 284.2M (2024-06-30); 2.2x the same period a year earlier
6 Jun 20248-K and other filingsDirector or officer change
6 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 May 2024Sharp changeQuarterly revenue change: quarterly revenue change, 606.7M vs usual 275.6M (2024-03-31); 2.2x the same period a year earlier
27 Feb 2024Sharp changeQuarterly revenue change: quarterly revenue change, 616.5M vs usual 269.1M (2023-12-31); 2.2x the same period a year earlier
5 Feb 20248-K and other filingsDirector or officer change
5 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Nov 2023Sharp changeQuarterly revenue change: quarterly revenue change, 383.6M vs usual 258.9M (2023-09-30); 1.5x the same period a year earlier
19 Sep 2023Sharp changeShort interest spike: short interest spike, 10.6M vs usual 5.3M (2023-08-31); 2.0x the same period a year earlier
1 Sep 20238-K and other filingsDirector or officer change
1 Sep 20238-K and other filingsCompleted an acquisition or asset sale
15 Aug 2023Sharp changeShort interest spike: short interest spike, 8.1M vs usual 5.2M (2023-07-31); 1.6x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 8.2M vs usual 5.1M (2023-07-14); 1.7x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 7.9M vs usual 5.0M (2023-06-30); 1.7x the same period a year earlier
4 Jul 2023Sharp changeShort interest spike: short interest spike, 7.7M vs usual 5.0M (2023-06-15); 1.7x the same period a year earlier
13 Jun 2023Sharp changeShort interest spike: short interest spike, 8.0M vs usual 4.9M (2023-05-31); 1.8x the same period a year earlier
8 Jun 20238-K and other filingsDirector or officer change
8 Jun 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 May 2023Sharp changeShort interest spike: short interest spike, 7.7M vs usual 4.9M (2023-05-15); 1.7x the same period a year earlier
16 May 2023Sharp changeMany funds opening a new position: many funds opening a new position, 79 vs usual 39.50 (2023-03-31); 2.3x the same period a year earlier
13 Sep 2022Sharp changeShort interest spike: short interest spike, 5.2M vs usual 1.3M (2022-08-31); 4.6x the same period a year earlier
30 Aug 2022Sharp changeShort interest spike: short interest spike, 5.2M vs usual 1.3M (2022-08-15); 4.5x the same period a year earlier
16 Aug 2022Sharp changeShort interest spike: short interest spike, 5.0M vs usual 1.3M (2022-07-29); 3.6x the same period a year earlier
2 Aug 2022Sharp changeShort interest spike: short interest spike, 5.0M vs usual 1.3M (2022-07-15); 3.4x the same period a year earlier
19 Jul 2022Sharp changeShort interest spike: short interest spike, 4.7M vs usual 1.3M (2022-06-30); 3.3x the same period a year earlier
28 Jun 2022Sharp changeShort interest spike: short interest spike, 4.6M vs usual 1.2M (2022-06-15); 3.4x the same period a year earlier
14 Jun 2022Sharp changeShort interest spike: short interest spike, 4.5M vs usual 1.2M (2022-05-31); 3.7x the same period a year earlier
3 Jun 20228-K and other filingsDirector or officer change
31 May 2022Sharp changeShort interest spike: short interest spike, 4.4M vs usual 1.2M (2022-05-13); 3.6x the same period a year earlier
17 May 2022Sharp changeShort interest spike: short interest spike, 3.4M vs usual 1.2M (2022-04-29); 1.7x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 3.9M vs usual 1.2M (2022-04-14); 2.6x the same period a year earlier
21 Apr 20228-K and other filingsDirector or officer change
21 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Apr 2022Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.2M (2022-03-31); 2.0x the same period a year earlier
29 Mar 2022Sharp changeShort interest spike: short interest spike, 2.3M vs usual 1.2M (2022-03-15); 1.9x the same period a year earlier
Insider net buying (open market)
Month from 1 Mar 2022: -$1.6M published
Month from 1 Apr 2022: -$2.6M published
Month from 1 Dec 2022: -$562K published
Month from 1 Feb 2023: -$2.3M published
Month from 1 May 2023: -$2.5M published
Month from 1 Mar 2024: -$956K published
Month from 1 May 2024: -$5.4M published
Month from 1 Jul 2024: -$70K published
Month from 1 Sep 2024: -$2.8M published
Month from 1 Oct 2024: -$4.3M published
Month from 1 Nov 2024: -$20.9M published
Month from 1 Dec 2024: -$218K published
Month from 1 Jan 2025: -$1.3M published
Month from 1 Mar 2025: -$590K published
Month from 1 Sep 2025: -$585K published
Month from 1 Nov 2025: -$5.8M published
Month from 1 Dec 2025: -$2.0M published
Month from 1 Jan 2026: -$566K published
Month from 1 Feb 2026: -$2.8M published
Month from 1 Jun 2026: -$2.0M published
Month from 1 Aug 2026: -$2.2M published
Month from 1 Sep 2026: -$2.2M published
Month from 1 Nov 2026: -$3.6M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Apr 2022: 2 published
Quarter from 1 Jul 2022: 4 published
Quarter from 1 Oct 2022: 1 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Jul 2023: 10 published
Quarter from 1 Oct 2023: 2 published
Quarter from 1 Jan 2024: 1 published
Quarter from 1 Apr 2024: 3 published
Quarter from 1 Jul 2024: 7 published
Quarter from 1 Oct 2024: 6 published
Quarter from 1 Jan 2025: 4 published
Quarter from 1 Apr 2025: 2 published
Quarter from 1 Jul 2025: 10 published
Quarter from 1 Oct 2025: 9 published
Quarter from 1 Jan 2026: 4 published
Quarter from 1 Apr 2026: 4 published
Quarter from 1 Jul 2026: 17 published
Quarter from 1 Oct 2026: 8 published
Revenue per quarter
Quarter ended 31 Dec 2021: $250.0M, +7.1% on a year earlier; public on 18 Feb 2022
Quarter ended 31 Mar 2022: $230.5M, +1.4% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $263.6M, +5.0% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $254.1M, +11% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $274.5M, +9.8% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $276.7M, +20% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $291.6M, +11% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $383.6M, +51% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $616.5M, +125% on a year earlier; public on 22 Feb 2024
Quarter ended 31 Mar 2024: $606.7M, +119% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $629.7M, +116% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $625.7M, +63% on a year earlier; public on 6 Nov 2024
Quarter ended 31 Dec 2024: $657.3M, +6.6% on a year earlier; public on 21 Feb 2025
Quarter ended 31 Mar 2025: $598.1M, -1.4% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $745.3M, +18% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $769.0M, +23% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $826.4M, +26% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $759.9M, +27% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $789.6M, +5.9% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $763.7M, -0.7% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $17.0M, +21% on a year earlier; public on 18 Feb 2022
Quarter ended 31 Mar 2022: $20.0M, +46% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $23.8M, +183% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $12.0M, -33% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $18.3M, +7.6% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $16.0M, -20% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $17.9M, -25% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $21.5M, +80% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $22.9M, +25% on a year earlier; public on 22 Feb 2024
Quarter ended 31 Mar 2024: $28.6M, +79% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $27.8M, +56% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $42.0M, +95% on a year earlier; public on 6 Nov 2024
Quarter ended 31 Dec 2024: $17.1M, -25% on a year earlier; public on 21 Feb 2025
Quarter ended 31 Mar 2025: $36.1M, +26% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $46.6M, +68% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $35.8M, -15% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $46.2M, +170% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $39.6M, +9.7% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $33.2M, -29% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $40.4M, +13% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 332; public on 14 Feb 2022
31 Mar 2022 report: 353; public on 16 May 2022
30 Jun 2022 report: 342; public on 15 Aug 2022
30 Sep 2022 report: 333; public on 14 Nov 2022
31 Dec 2022 report: 356; public on 14 Feb 2023
31 Mar 2023 report: 360; public on 15 May 2023
30 Jun 2023 report: 344; public on 14 Aug 2023
30 Sep 2023 report: 393; public on 14 Nov 2023
31 Dec 2023 report: 384; public on 14 Feb 2024
31 Mar 2024 report: 422; public on 15 May 2024
30 Jun 2024 report: 421; public on 14 Aug 2024
30 Sep 2024 report: 421; public on 14 Nov 2024
31 Dec 2024 report: 478; public on 14 Feb 2025
31 Mar 2025 report: 491; public on 15 May 2025
30 Jun 2025 report: 465; public on 14 Aug 2025
30 Sep 2025 report: 465; public on 14 Nov 2025
31 Dec 2025 report: 543; public on 17 Feb 2026
31 Mar 2026 report: 588; public on 15 May 2026
30 Jun 2026 report: 586; public on 14 Aug 2026
30 Sep 2026 report: 611; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $131K published
Month from 1 Dec 2021: $220K published
Month from 1 Jan 2022: $528K published
Month from 1 Feb 2022: $468K published
Month from 1 Mar 2022: $2.4M published
Month from 1 Apr 2022: $216K published
Month from 1 May 2022: $378K published
Month from 1 Jun 2022: $59K published
Month from 1 Jul 2022: $238K published
Month from 1 Aug 2022: $297K published
Month from 1 Sep 2022: $1.2M published
Month from 1 Oct 2022: $199K published
Month from 1 Nov 2022: $161K published
Month from 1 Dec 2022: $75K published
Month from 1 Jan 2023: $304K published
Month from 1 Feb 2023: $284K published
Month from 1 Mar 2023: $419K published
Month from 1 Apr 2023: $186K published
Month from 1 May 2023: $180K published
Month from 1 Jun 2023: $268K published
Month from 1 Jul 2023: $211K published
Month from 1 Aug 2023: $617K published
Month from 1 Sep 2023: $620K published
Month from 1 Oct 2023: $334K published
Month from 1 Nov 2023: $384K published
Month from 1 Dec 2023: $174K published
Month from 1 Jan 2024: $203K published
Month from 1 Feb 2024: $143K published
Month from 1 Mar 2024: $307K published
Month from 1 Apr 2024: $182K published
Month from 1 May 2024: $447K published
Month from 1 Jun 2024: $67K published
Month from 1 Jul 2024: $211K published
Month from 1 Aug 2024: $280K published
Month from 1 Sep 2024: $142K published
Month from 1 Oct 2024: $129K published
Month from 1 Nov 2024: $148K published
Month from 1 Dec 2024: $28K published
Month from 1 Jan 2025: $209K published
Month from 1 Feb 2025: $191K published
Month from 1 Mar 2025: $246K published
Month from 1 Apr 2025: $171K published
Month from 1 May 2025: $328K published
Month from 1 Jun 2025: $92K published
Month from 1 Jul 2025: $206K published
Month from 1 Aug 2025: $154K published
Month from 1 Sep 2025: $75K published
Month from 1 Oct 2025: $109K published
Month from 1 Nov 2025: $137K published
Month from 1 Dec 2025: $248K published
Month from 1 Jan 2026: $84K published
Month from 1 Feb 2026: $112K published
Month from 1 Mar 2026: $196K published
Month from 1 Apr 2026: $228K published
Month from 1 May 2026: $218K published
Month from 1 Jun 2026: $189K published
Month from 1 Jul 2026: $92K published
Month from 1 Aug 2026: $220K published
Month from 1 Sep 2026: $301K published
Month from 1 Oct 2026: $30K published
Month from 1 Nov 2026: $91K published
Lobbying spend
Quarter from 1 Apr 2023: $40K published
Quarter from 1 Jul 2023: $40K published
Quarter from 1 Oct 2023: $40K published
Quarter from 1 Jan 2024: $40K published
Quarter from 1 Apr 2024: $40K published
Quarter from 1 Jul 2024: $40K published
Quarter from 1 Oct 2024: $40K published
Quarter from 1 Jan 2025: $40K published
Quarter from 1 Apr 2025: $40K published
Quarter from 1 Jul 2025: $40K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $3.1M (12 Nov 2026), 2.5× its normal reading; higher than 79% of its own history.
  • Insider net buying (open market): Insiders sold a net $15.3M in the last 12 months (the 12 months before: -$8.4M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 33 published in the last 12 months, +32% on the 12 months before.
  • Revenue per quarter: Revenue $763.7M in the latest quarter, -0.7% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 94 insider trades

Last 90 days: 3 sales, $5.8M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
12 Nov 2026James R TobinDirectorSellafter exercising options41,666$75.16$3.1MForm 4
5 Nov 2026Ann D RhoadsDirectorSellplanned in advance (10b5-1)5,000$85.00$425KForm 4
16 Sep 2026James R TobinDirectorSellafter exercising options30,000$74.58$2.2MForm 4
19 Aug 2026Stephen T ZarrilliDirectorSellafter exercising options25,000$87.04$2.2MForm 4
9 Jun 2026David D DavidarDirectorSellafter exercising options25,000$80.76$2.0MForm 4
27 Feb 2026Kelly HullerEVP, GC, Corporate SecretarySellplanned in advance (10b5-1); after exercising options20,000$94.50$1.9MForm 4
17 Feb 2026Kelly HullerEVP, GC, Corporate SecretarySellplanned in advance (10b5-1); after exercising options10,000$87.67$877KForm 4
12 Jan 2026Kyle KlineSenior Vice President, CFOSellplanned in advance (10b5-1); after exercising options3,594$101.10$363KForm 4

611 institutions reported shares at the end of Q3 2026, 89% of the shares outstanding; 82 opened a position, 61 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.10.9M8.12%$816.9M+99K+0.9%
Janus Henderson Group Ltd.8.6M6.43%$646.7M
Vanguard Capital Management LLC5.1M3.78%$380.2M-32K-0.6%
Vanguard Portfolio Management LLC4.9M3.62%$364.5M-128K-2.6%
State Street Corp3.7M2.77%$278.5M+4,524+0.1%
Boston Partners3.4M2.54%$255.9M+1.9M+120%
Kayne Anderson Rudnick Investment Management LLC3.2M2.38%$239.4M-1.1M-25%
JPMorgan Chase & Co3.2M2.35%$239.5M+415K+15%
Dimensional Fund Advisors LP3.0M2.24%$225.3M+638K+27%
Swedbank AB2.9M2.15%$215.8M+2.4M+454%

Company events

All 27 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
4 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
23 Mar 2026Director or officer change8-K
21 Jul 2025Director or officer change8-K
5 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
3 Apr 2025Completed an acquisition or asset sale8-K
6 Feb 2025Signed a major agreement8-K
6 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
5 Feb 2024Director or officer change8-K

Reported lobbying spend: $40K in Q2 2025, $40K in Q1 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
30 Sep 2026EndedBallard Spahr LLPfor Globus Medical, Inc.Not statedFiling
1 Jul 2025EndedJeffrey J. Kimbell & Associates, Inc.for Nevro CorporationNot statedFiling
28 Feb 2021EndedPolsinelli PCfor Simplify Medical, Inc.Medicare reimbursement issue pertaining to surgical implantsMedicare/MedicaidFiling
21 Feb 2020NewPolsinelli PCfor Simplify Medical, Inc.Medicare reimbursement issue pertaining to surgical implantsMedicare/MedicaidFiling
31 Jan 2019EndedJ P Ford Strategies, LLCfor Nevro CorporationNot statedFiling
14 Jan 2019NewBallard Spahr LLPfor Globus Medical, Inc.Sunshine Act provisions in the Affordable Care Act; Medical device tax repealHealth issues, Taxation, Medicare/MedicaidFiling
1 Sep 2018NewJ P Ford Strategies, LLCfor Nevro CorporationFederal policy issues related to non-opioid chronic pain therapies.Health issues, Medicare/MedicaidFiling
31 Jul 2018EndedSidley Austin LLPfor Nevro Corp.Legislation addressing non-opioid pain managementHealth issuesFiling

The 5 newest of 275 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

30 May 2023confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Globus Medical (GMED): saw 79 13F filers open a new position in the quarter ended 31 Mar 2023, 2.3× the same quarter last year, while it had 8.0M shares sold short in the 31 May 2023 report, 1.8× the same report last year. Two unrelated kinds of activity within 91 days.

  • Institutional holdings: Many funds opening a new position, became public on 15 May 2023
  • Short interest and volume: Short interest spike, became public on 25 May 2023
  • Short interest and volume: Short interest spike, became public on 10 Jun 2023
  • Short interest and volume: Short interest spike, became public on 28 Jun 2023
  • Short interest and volume: Short interest spike, became public on 13 Jul 2023
  • Short interest and volume: Short interest spike, became public on 26 Jul 2023
  • Short interest and volume: Short interest spike, became public on 10 Aug 2023
2021-03-31: 352021-06-30: 432021-09-30: 512021-12-31: 242022-03-31: 352022-06-30: 502022-09-30: 362022-12-31: 522023-03-31: 79
The quarter ended 31 Mar 2023 against the 8 quarters before it. this quarterearliernormal: 39.5
See the evidence (7 changes)

Institutional holdings: Many funds opening a new position became public on 15 May 2023

Globus Medical saw 79 13F filers open a new position in the quarter ended 31 Mar 2023, 2.3× the same quarter last year.

This period
79 (the quarter ended 31 Mar 2023)
Normal quarter (median of 8 earlier)
39.5
Typical spread (median absolute deviation)
7.5
How far from its usual level
+3.6
Same quarter last year
35
History used
3,469 days
2021-03-31: 352021-06-30: 432021-09-30: 512021-12-31: 242022-03-31: 352022-06-30: 502022-09-30: 362022-12-31: 522023-03-31: 79
the quarter ended 31 Mar 20238 earlier quartersnormal: 39.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 25 May 2023

Globus Medical had 7.7M shares sold short in the 15 May 2023 report, 1.7× the same report last year.

This period
7.7M (the 15 May 2023 report)
Normal report (median of 24 earlier)
4.9M
Typical spread (median absolute deviation)
282K
How far from its usual level
+5.7
Same report last year
4.4M
History used
1,963 days
2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M
the 15 May 2023 report24 earlier reportsnormal: 4.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Jun 2023

Globus Medical had 8.0M shares sold short in the 31 May 2023 report, 1.8× the same report last year.

This period
8.0M (the 31 May 2023 report)
Normal report (median of 24 earlier)
4.9M
Typical spread (median absolute deviation)
266K
How far from its usual level
+6.3
Same report last year
4.5M
History used
1,979 days
2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M
the 31 May 2023 report24 earlier reportsnormal: 4.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Jun 2023

Globus Medical had 7.7M shares sold short in the 15 Jun 2023 report, 1.7× the same report last year.

This period
7.7M (the 15 Jun 2023 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
258K
How far from its usual level
+5.5
Same report last year
4.6M
History used
1,994 days
2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M
the 15 Jun 2023 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Jul 2023

Globus Medical had 7.9M shares sold short in the 30 Jun 2023 report, 1.7× the same report last year.

This period
7.9M (the 30 Jun 2023 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
293K
How far from its usual level
+5.7
Same report last year
4.7M
History used
2,009 days
2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M
the 30 Jun 2023 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jul 2023

Globus Medical had 8.2M shares sold short in the 14 Jul 2023 report, 1.7× the same report last year.

This period
8.2M (the 14 Jul 2023 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
312K
How far from its usual level
+6.2
Same report last year
5.0M
History used
2,023 days
2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M2023-07-14: 8.2M
the 14 Jul 2023 report24 earlier reportsnormal: 5.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Aug 2023

Globus Medical had 8.1M shares sold short in the 31 Jul 2023 report, 1.6× the same report last year.

This period
8.1M (the 31 Jul 2023 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
509K
How far from its usual level
+3.9
Same report last year
5.0M
History used
2,040 days
2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M2023-07-14: 8.2M2023-07-31: 8.1M
the 31 Jul 2023 report24 earlier reportsnormal: 5.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 21 Oct 2026Lobbying record

    GLOBUS MEDICAL, INC.: lobbying engagement terminated (BALLARD SPAHR LLP) (dated 30 Sep 2026)

  2. 13 Aug 2026Institutional holdings record

    KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC opened a $338.0M position (2026Q2 13F)

  3. 4 Jun 2026Filings record

    Director or officer change

  4. 23 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 23 Mar 2026Filings record

    Director or officer change

  6. 26 Feb 2026Financials change

    reported revenue of $826.4M for the quarter ended 31 Dec 2025, 1.3× the same quarter last year.

    Same quarter last year: $657.3M; its normal quarter is $627.7M.

    See the evidence
    This period
    $826.4M (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    $627.7M
    Typical spread (median absolute deviation)
    $25.3M
    How far from its usual level
    +3.2
    Same quarter last year
    $657.3M
    History used
    3,562 days
    2023-12-31: $616.5M2024-03-31: $606.7M2024-06-30: $629.7M2024-09-30: $625.7M2024-12-31: $657.3M2025-03-31: $598.1M2025-06-30: $745.3M2025-09-30: $769.0M2025-12-31: $826.4M
    the quarter ended 31 Dec 20258 earlier quartersnormal: $627.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  7. 21 Jul 2025Filings record

    Director or officer change

  8. 5 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 5 Jun 2025Filings record

    Director or officer change

  10. 3 Apr 2025Filings record

    Completed an acquisition or asset sale

  11. 12 Nov 2024Financials change

    spent $42.0M on capital projects in the quarter ended 30 Sep 2024, 1.9× the same quarter last year.

    Same quarter last year: $21.5M; its normal quarter is $19.9M.

    See the evidence
    This period
    $42.0M (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    $19.9M
    Typical spread (median absolute deviation)
    $3.4M
    How far from its usual level
    +4.3
    Same quarter last year
    $21.5M
    History used
    4,749 days
    2022-09-30: $12.0M2022-12-31: $18.3M2023-03-31: $16.0M2023-06-30: $17.9M2023-09-30: $21.5M2023-12-31: $22.9M2024-03-31: $28.6M2024-06-30: $27.8M2024-09-30: $42.0M
    the quarter ended 30 Sep 20248 earlier quartersnormal: $19.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  12. 13 Aug 2024Financials change

    reported revenue of $629.7M for the quarter ended 30 Jun 2024, 2.2× the same quarter last year.

    Same quarter last year: $291.6M; its normal quarter is $284.2M.

    See the evidence
    This period
    $629.7M (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    $284.2M
    Typical spread (median absolute deviation)
    $25.3M
    How far from its usual level
    +9.2
    Same quarter last year
    $291.6M
    History used
    4,840 days
    2022-06-30: $263.6M2022-09-30: $254.1M2022-12-31: $274.5M2023-03-31: $276.7M2023-06-30: $291.6M2023-09-30: $383.6M2023-12-31: $616.5M2024-03-31: $606.7M2024-06-30: $629.7M
    the quarter ended 30 Jun 20248 earlier quartersnormal: $284.2M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  13. 6 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 6 Jun 2024Filings record

    Director or officer change

  15. 14 May 2024Financials change

    reported revenue of $606.7M for the quarter ended 31 Mar 2024, 2.2× the same quarter last year.

    Same quarter last year: $276.7M; its normal quarter is $275.6M.

    See the evidence
    This period
    $606.7M (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $275.6M
    Typical spread (median absolute deviation)
    $18.7M
    How far from its usual level
    +11.9
    Same quarter last year
    $276.7M
    History used
    4,749 days
    2022-03-31: $230.5M2022-06-30: $263.6M2022-09-30: $254.1M2022-12-31: $274.5M2023-03-31: $276.7M2023-06-30: $291.6M2023-09-30: $383.6M2023-12-31: $616.5M2024-03-31: $606.7M
    the quarter ended 31 Mar 20248 earlier quartersnormal: $275.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  16. 27 Feb 2024Financials change

    reported revenue of $616.5M for the quarter ended 31 Dec 2023, 2.2× the same quarter last year.

    Same quarter last year: $274.5M; its normal quarter is $269.1M.

    See the evidence
    This period
    $616.5M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $269.1M
    Typical spread (median absolute deviation)
    $17.0M
    How far from its usual level
    +12.9
    Same quarter last year
    $274.5M
    History used
    4,658 days
    2021-12-31: $250.0M2022-03-31: $230.5M2022-06-30: $263.6M2022-09-30: $254.1M2022-12-31: $274.5M2023-03-31: $276.7M2023-06-30: $291.6M2023-09-30: $383.6M2023-12-31: $616.5M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $269.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  17. 5 Feb 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 5 Feb 2024Filings record

    Director or officer change

  19. 14 Nov 2023Financials change

    reported revenue of $383.6M for the quarter ended 30 Sep 2023, 1.5× the same quarter last year.

    Same quarter last year: $254.1M; its normal quarter is $258.9M.

    See the evidence
    This period
    $383.6M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $258.9M
    Typical spread (median absolute deviation)
    $16.7M
    How far from its usual level
    +4.8
    Same quarter last year
    $254.1M
    History used
    4,566 days
    2021-09-30: $229.7M2021-12-31: $250.0M2022-03-31: $230.5M2022-06-30: $263.6M2022-09-30: $254.1M2022-12-31: $274.5M2023-03-31: $276.7M2023-06-30: $291.6M2023-09-30: $383.6M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $258.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  20. 13 Sep 2023Short interest and volume change

    had 10.6M shares sold short in the 31 Aug 2023 report, 2.0× the same report last year.

    Same report last year: 5.2M; its normal report is 5.3M.

    See the evidence
    This period
    10.6M (the 31 Aug 2023 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    589K
    How far from its usual level
    +6.0
    Same report last year
    5.2M
    History used
    2,071 days
    2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M2023-07-14: 8.2M2023-07-31: 8.1M2023-08-15: 8.0M2023-08-31: 10.6M
    the 31 Aug 2023 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 1 Sep 2023Filings record

    Director or officer change

  22. 1 Sep 2023Filings record

    Completed an acquisition or asset sale

  23. 10 Aug 2023Short interest and volume change

    had 8.1M shares sold short in the 31 Jul 2023 report, 1.6× the same report last year.

    Same report last year: 5.0M; its normal report is 5.2M.

    See the evidence
    This period
    8.1M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    509K
    How far from its usual level
    +3.9
    Same report last year
    5.0M
    History used
    2,040 days
    2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M2023-07-14: 8.2M2023-07-31: 8.1M
    the 31 Jul 2023 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 26 Jul 2023Short interest and volume change

    had 8.2M shares sold short in the 14 Jul 2023 report, 1.7× the same report last year.

    Same report last year: 5.0M; its normal report is 5.1M.

    See the evidence
    This period
    8.2M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    312K
    How far from its usual level
    +6.2
    Same report last year
    5.0M
    History used
    2,023 days
    2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M2023-07-14: 8.2M
    the 14 Jul 2023 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 13 Jul 2023Short interest and volume change

    had 7.9M shares sold short in the 30 Jun 2023 report, 1.7× the same report last year.

    Same report last year: 4.7M; its normal report is 5.0M.

    See the evidence
    This period
    7.9M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    293K
    How far from its usual level
    +5.7
    Same report last year
    4.7M
    History used
    2,009 days
    2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M
    the 30 Jun 2023 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 28 Jun 2023Short interest and volume change

    had 7.7M shares sold short in the 15 Jun 2023 report, 1.7× the same report last year.

    Same report last year: 4.6M; its normal report is 5.0M.

    See the evidence
    This period
    7.7M (the 15 Jun 2023 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    258K
    How far from its usual level
    +5.5
    Same report last year
    4.6M
    History used
    1,994 days
    2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M
    the 15 Jun 2023 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 10 Jun 2023Short interest and volume change

    had 8.0M shares sold short in the 31 May 2023 report, 1.8× the same report last year.

    Same report last year: 4.5M; its normal report is 4.9M.

    See the evidence
    This period
    8.0M (the 31 May 2023 report)
    Normal report (median of 24 earlier)
    4.9M
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +6.3
    Same report last year
    4.5M
    History used
    1,979 days
    2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M
    the 31 May 2023 report24 earlier reportsnormal: 4.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 8 Jun 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 8 Jun 2023Filings record

    Director or officer change

  30. 30 May 2023several at once

    saw 79 13F filers open a new position in the quarter ended 31 Mar 2023, 2.3× the same quarter last year, while it had 8.0M shares sold short in the 31 May 2023 report, 1.8× the same report last year. Two unrelated kinds of activity within 91 days.

    See the evidence (7 changes)

    Institutional holdings: Many funds opening a new position became public on 15 May 2023

    Globus Medical saw 79 13F filers open a new position in the quarter ended 31 Mar 2023, 2.3× the same quarter last year.

    This period
    79 (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    39.5
    Typical spread (median absolute deviation)
    7.5
    How far from its usual level
    +3.6
    Same quarter last year
    35
    History used
    3,469 days
    2021-03-31: 352021-06-30: 432021-09-30: 512021-12-31: 242022-03-31: 352022-06-30: 502022-09-30: 362022-12-31: 522023-03-31: 79
    the quarter ended 31 Mar 20238 earlier quartersnormal: 39.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 25 May 2023

    Globus Medical had 7.7M shares sold short in the 15 May 2023 report, 1.7× the same report last year.

    This period
    7.7M (the 15 May 2023 report)
    Normal report (median of 24 earlier)
    4.9M
    Typical spread (median absolute deviation)
    282K
    How far from its usual level
    +5.7
    Same report last year
    4.4M
    History used
    1,963 days
    2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M
    the 15 May 2023 report24 earlier reportsnormal: 4.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Jun 2023

    Globus Medical had 8.0M shares sold short in the 31 May 2023 report, 1.8× the same report last year.

    This period
    8.0M (the 31 May 2023 report)
    Normal report (median of 24 earlier)
    4.9M
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +6.3
    Same report last year
    4.5M
    History used
    1,979 days
    2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M
    the 31 May 2023 report24 earlier reportsnormal: 4.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 28 Jun 2023

    Globus Medical had 7.7M shares sold short in the 15 Jun 2023 report, 1.7× the same report last year.

    This period
    7.7M (the 15 Jun 2023 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    258K
    How far from its usual level
    +5.5
    Same report last year
    4.6M
    History used
    1,994 days
    2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M
    the 15 Jun 2023 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 13 Jul 2023

    Globus Medical had 7.9M shares sold short in the 30 Jun 2023 report, 1.7× the same report last year.

    This period
    7.9M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    293K
    How far from its usual level
    +5.7
    Same report last year
    4.7M
    History used
    2,009 days
    2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M
    the 30 Jun 2023 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Jul 2023

    Globus Medical had 8.2M shares sold short in the 14 Jul 2023 report, 1.7× the same report last year.

    This period
    8.2M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    312K
    How far from its usual level
    +6.2
    Same report last year
    5.0M
    History used
    2,023 days
    2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M2023-07-14: 8.2M
    the 14 Jul 2023 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Aug 2023

    Globus Medical had 8.1M shares sold short in the 31 Jul 2023 report, 1.6× the same report last year.

    This period
    8.1M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    509K
    How far from its usual level
    +3.9
    Same report last year
    5.0M
    History used
    2,040 days
    2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M2023-05-31: 8.0M2023-06-15: 7.7M2023-06-30: 7.9M2023-07-14: 8.2M2023-07-31: 8.1M
    the 31 Jul 2023 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  31. 25 May 2023Short interest and volume change

    had 7.7M shares sold short in the 15 May 2023 report, 1.7× the same report last year.

    Same report last year: 4.4M; its normal report is 4.9M.

    See the evidence
    This period
    7.7M (the 15 May 2023 report)
    Normal report (median of 24 earlier)
    4.9M
    Typical spread (median absolute deviation)
    282K
    How far from its usual level
    +5.7
    Same report last year
    4.4M
    History used
    1,963 days
    2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M2022-09-15: 4.8M2022-09-30: 4.9M2022-10-14: 4.9M2022-10-31: 5.4M2022-11-15: 5.8M2022-11-30: 5.9M2022-12-15: 5.0M2022-12-30: 4.8M2023-01-13: 4.9M2023-01-31: 4.9M2023-02-15: 2.6M2023-02-28: 3.9M2023-03-15: 4.5M2023-03-31: 5.1M2023-04-14: 5.8M2023-04-28: 6.2M2023-05-15: 7.7M
    the 15 May 2023 report24 earlier reportsnormal: 4.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 15 May 2023Institutional holdings change

    saw 79 13F filers open a new position in the quarter ended 31 Mar 2023, 2.3× the same quarter last year.

    Same quarter last year: 35; its normal quarter is 39.5.

    See the evidence
    This period
    79 (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    39.5
    Typical spread (median absolute deviation)
    7.5
    How far from its usual level
    +3.6
    Same quarter last year
    35
    History used
    3,469 days
    2021-03-31: 352021-06-30: 432021-09-30: 512021-12-31: 242022-03-31: 352022-06-30: 502022-09-30: 362022-12-31: 522023-03-31: 79
    the quarter ended 31 Mar 20238 earlier quartersnormal: 39.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  33. 14 Feb 2023Institutional holdings record

    KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC opened a $459.0M position (2022Q4 13F)

  34. 13 Sep 2022Short interest and volume change

    had 5.2M shares sold short in the 31 Aug 2022 report, 4.6× the same report last year.

    Same report last year: 1.1M; its normal report is 1.3M.

    See the evidence
    This period
    5.2M (the 31 Aug 2022 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    549K
    How far from its usual level
    +4.8
    Same report last year
    1.1M
    History used
    1,706 days
    2021-08-13: 1.2M2021-08-31: 1.1M2021-09-15: 1.2M2021-09-30: 1.2M2021-10-15: 1.3M2021-10-29: 1.1M2021-11-15: 782K2021-11-30: 808K2021-12-15: 1.0M2022-01-14: 747K2022-01-31: 955K2022-02-15: 1.3M2022-02-28: 952K2022-03-15: 2.3M2022-03-31: 2.6M2022-04-14: 3.9M2022-04-29: 3.4M2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M2022-08-31: 5.2M
    the 31 Aug 2022 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 25 Aug 2022Short interest and volume change

    had 5.2M shares sold short in the 15 Aug 2022 report, 4.5× the same report last year.

    Same report last year: 1.2M; its normal report is 1.3M.

    See the evidence
    This period
    5.2M (the 15 Aug 2022 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    518K
    How far from its usual level
    +5.1
    Same report last year
    1.2M
    History used
    1,690 days
    2021-07-30: 1.4M2021-08-13: 1.2M2021-08-31: 1.1M2021-09-15: 1.2M2021-09-30: 1.2M2021-10-15: 1.3M2021-10-29: 1.1M2021-11-15: 782K2021-11-30: 808K2021-12-15: 1.0M2022-01-14: 747K2022-01-31: 955K2022-02-15: 1.3M2022-02-28: 952K2022-03-15: 2.3M2022-03-31: 2.6M2022-04-14: 3.9M2022-04-29: 3.4M2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M2022-08-15: 5.2M
    the 15 Aug 2022 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 10 Aug 2022Short interest and volume change

    had 5.0M shares sold short in the 29 Jul 2022 report, 3.6× the same report last year.

    Same report last year: 1.4M; its normal report is 1.3M.

    See the evidence
    This period
    5.0M (the 29 Jul 2022 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    433K
    How far from its usual level
    +5.8
    Same report last year
    1.4M
    History used
    1,673 days
    2021-07-15: 1.4M2021-07-30: 1.4M2021-08-13: 1.2M2021-08-31: 1.1M2021-09-15: 1.2M2021-09-30: 1.2M2021-10-15: 1.3M2021-10-29: 1.1M2021-11-15: 782K2021-11-30: 808K2021-12-15: 1.0M2022-01-14: 747K2022-01-31: 955K2022-02-15: 1.3M2022-02-28: 952K2022-03-15: 2.3M2022-03-31: 2.6M2022-04-14: 3.9M2022-04-29: 3.4M2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M2022-07-29: 5.0M
    the 29 Jul 2022 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 27 Jul 2022Short interest and volume change

    had 5.0M shares sold short in the 15 Jul 2022 report, 3.4× the same report last year.

    Same report last year: 1.4M; its normal report is 1.3M.

    See the evidence
    This period
    5.0M (the 15 Jul 2022 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    360K
    How far from its usual level
    +6.8
    Same report last year
    1.4M
    History used
    1,659 days
    2021-06-30: 1.4M2021-07-15: 1.4M2021-07-30: 1.4M2021-08-13: 1.2M2021-08-31: 1.1M2021-09-15: 1.2M2021-09-30: 1.2M2021-10-15: 1.3M2021-10-29: 1.1M2021-11-15: 782K2021-11-30: 808K2021-12-15: 1.0M2022-01-14: 747K2022-01-31: 955K2022-02-15: 1.3M2022-02-28: 952K2022-03-15: 2.3M2022-03-31: 2.6M2022-04-14: 3.9M2022-04-29: 3.4M2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M2022-07-15: 5.0M
    the 15 Jul 2022 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 13 Jul 2022Short interest and volume change

    had 4.7M shares sold short in the 30 Jun 2022 report, 3.3× the same report last year.

    Same report last year: 1.4M; its normal report is 1.3M.

    See the evidence
    This period
    4.7M (the 30 Jun 2022 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    323K
    How far from its usual level
    +7.1
    Same report last year
    1.4M
    History used
    1,644 days
    2021-06-15: 1.4M2021-06-30: 1.4M2021-07-15: 1.4M2021-07-30: 1.4M2021-08-13: 1.2M2021-08-31: 1.1M2021-09-15: 1.2M2021-09-30: 1.2M2021-10-15: 1.3M2021-10-29: 1.1M2021-11-15: 782K2021-11-30: 808K2021-12-15: 1.0M2022-01-14: 747K2022-01-31: 955K2022-02-15: 1.3M2022-02-28: 952K2022-03-15: 2.3M2022-03-31: 2.6M2022-04-14: 3.9M2022-04-29: 3.4M2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M2022-06-30: 4.7M
    the 30 Jun 2022 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 28 Jun 2022Short interest and volume change

    had 4.6M shares sold short in the 15 Jun 2022 report, 3.4× the same report last year.

    Same report last year: 1.4M; its normal report is 1.2M.

    See the evidence
    This period
    4.6M (the 15 Jun 2022 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    210K
    How far from its usual level
    +10.8
    Same report last year
    1.4M
    History used
    1,629 days
    2021-05-28: 1.2M2021-06-15: 1.4M2021-06-30: 1.4M2021-07-15: 1.4M2021-07-30: 1.4M2021-08-13: 1.2M2021-08-31: 1.1M2021-09-15: 1.2M2021-09-30: 1.2M2021-10-15: 1.3M2021-10-29: 1.1M2021-11-15: 782K2021-11-30: 808K2021-12-15: 1.0M2022-01-14: 747K2022-01-31: 955K2022-02-15: 1.3M2022-02-28: 952K2022-03-15: 2.3M2022-03-31: 2.6M2022-04-14: 3.9M2022-04-29: 3.4M2022-05-13: 4.4M2022-05-31: 4.5M2022-06-15: 4.6M
    the 15 Jun 2022 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 10 Jun 2022Short interest and volume change

    had 4.5M shares sold short in the 31 May 2022 report, 3.7× the same report last year.

    Same report last year: 1.2M; its normal report is 1.2M.

    See the evidence
    This period
    4.5M (the 31 May 2022 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    206K
    How far from its usual level
    +10.8
    Same report last year
    1.2M
    History used
    1,614 days
    2021-05-14: 1.2M2021-05-28: 1.2M2021-06-15: 1.4M2021-06-30: 1.4M2021-07-15: 1.4M2021-07-30: 1.4M2021-08-13: 1.2M2021-08-31: 1.1M2021-09-15: 1.2M2021-09-30: 1.2M2021-10-15: 1.3M2021-10-29: 1.1M2021-11-15: 782K2021-11-30: 808K2021-12-15: 1.0M2022-01-14: 747K2022-01-31: 955K2022-02-15: 1.3M2022-02-28: 952K2022-03-15: 2.3M2022-03-31: 2.6M2022-04-14: 3.9M2022-04-29: 3.4M2022-05-13: 4.4M2022-05-31: 4.5M
    the 31 May 2022 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 83 entries; narrow the window or the kind of data to see older ones.

Not listed: 212 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001237831
Ticker
GMED
Domain
globusmedical.com
Employer name
Globus Medical, Inc., Globus Medical North America Inc (2 unverified)
Hq location
PA|AUDUBON|19403 (1 unverified)
Lobbying client
globus medical, simplify medical
Name
Branch Medical Group, LLC, Fibriant BV, Globus Medical Brazil LDTA, GLOBUS MEDICAL INC and 17 more
Uei
UUCZWL5MJ759, VTF5Y1Z1WVX9
Wikidata
Q18344949
Wikipedia
Globus Medical
  • DOL H-1B labor condition applications and PERM certifications415 data points17 Feb 2020 to 21 Sep 2026
  • Federal lobbying disclosures (LDA)14 records, 190 data points31 Mar 2008 to 30 Sep 2026
  • SEC Form 13F institutional holdings2 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)142 records6 Jan 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1096 data points31 Dec 2009 to 30 Sep 2026
  • SEC Form 4 insider transactions94 records, 328 data points6 Jan 2016 to 12 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards7647 data points4 Oct 2007 to 16 Nov 2026
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026